Navigation Links
Trails to detect effective breast cancer drugs that reduces recurrences

A quest for new drug has started to determine and help patients to have a recurrence free survival after breast cancer surgery. The chemotherapy drugs docetaxel (Taxotere) and vinorelbine (Navelbine) are tested to analyze the outcomes.//

It was previously reported by the Finnish researchers that patients who received infusions of trastuzumab (Herceptin) were less likely to get recurrences in the New England Journal of Medicine.

Dr. Heikki Joensuu, corresponding author and a physician at Helsinki University Central Hospital said that the breast cancer recurrence reduced by 42% during the first 3 years of follow-up among women treated with docetaxel when compared to those who received vinorelbine.

But on the other hand it was found that docetaxel was associated with more adverse effects such as allergic reactions, swelling and fever.

Joensuu and his colleagues conducted a study in more than a thousand women with breast cancer.

They gave them three cycles of either docetaxel or vinorelbine, followed by three cycles of other cancer drugs.

Then, a subgroup of 232 women was identified whose tumors had an amplified HER2/neu gene. This gene is known to be associated with cancers that grow and spread aggressively.

They were also assigned either to receive nine weeks of infusions of Herceptin or a placebo. By doing this the researchers were able to identify the best regime for recurrence-free survival.

The result of the study was that patients who received Herceptin had 58 % fewer cancer recurrences during the three-year follow-up than those who didn't get the drug. Previous studies also show that adjuvant trastuzumab [Herceptin] if taken for a course of one year reduces the rate of breast cancer recurrence by 50 % in women having HER2-positive breast cancer.

But it is not clearly understood about the optimal duration of the drug usage. Dr. Mark Pegram, director of the women's cancer pr ogram at the Jonsson Cancer Center at the David Geffen School of Medicine at UCLA said that if it is the short nine week regime that turns out to be ideal then it is great news. But still this question remains to be confirmed.


'"/>




Related medicine news :

1. Clinical Renal Trails Do Not Have Sufficient Women Participants
2. Clinicians Participating In the Pharmaceutical-Sponsored Trails Tend To Prescribe Their Drugs
3. CDC To Conduct Pre-clinical Trails Of BioDiems Intranasal Bird Flu Vaccine
4. Vitamin B12 can help in detecting cancers
5. “Brain fingerprinting”- The new lie detectr
6. Ductal lavage may detect early breast cancer
7. Better prostate cancer detection
8. Early detection of prostate cancer
9. Early detection of heart attack
10. Cytobrush to detect oral cancer
11. New device for detecting artery blockages
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... , ... December 07, 2016 , ... Levels of a ... damage, according to a study appearing online in the journal Radiology. , Heart disease ... to increase significantly due to the rapidly aging population. Damage to both organs often ...
(Date:12/7/2016)... ... , ... They are musicians and librarians, fashion designers and fitness instructors, actors, ... England and around the nation. What do they have in common? All have been ... and compelling new photographic exhibit debuting Friday, December 9 at Logan International Airport in ...
(Date:12/7/2016)... Hollywood, Fl (PRWEB) , ... December 07, 2016 , ... When it came time to ... new heart. Just 40 minutes later, the Pediatric Heart Transplant team at Joe ... true making the Weston teen the hospital’s 30th heart transplant recipient. , “He was ...
(Date:12/7/2016)... ... December 07, 2016 , ... ODU, ... to the US market its advanced highly customizable contact technology solutions. , ODU ... These advanced technologies are ideal for a wide range of applications that require ...
(Date:12/7/2016)... Arbor, MI (PRWEB) , ... December 07, 2016 ... ... insurance and financial consultation services from offices located in South Lyon, Dewitt, Williamston, ... to benefit a basketball coach who needs treatment for a brain tumor. , ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 A new study released ... (AIR 340B) projects the 340B Drug Pricing Program will continue ... time it is expected to exceed $23 billion in total ... 340B purchases surpass current Medicare Part B drug reimbursement purchases ... study – based on analysis of data on total drug ...
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - InMed ... progress today on its R&D program in the ... obstructive pulmonary disease (COPD). In June, 2015 InMed ... tool to identify the targets and potential active ... of COPD. Subsequently, with in vitro assays using ...
(Date:12/6/2016)... Tenn , Dec. 6, 2016  In response ... dependent on opioids every 25 minutes, a respected group ... company that will provide a holistic suite of services ... Based on his own experience trying to ... social entrepreneur Justin Lanning launched 180 ...
Breaking Medicine Technology: